These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20211328)

  • 1. Blunting of the heart rate response to adenosine and regadenoson in relation to hyperglycemia and the metabolic syndrome.
    Hage FG; Perry G; Heo J; Iskandrian AE
    Am J Cardiol; 2010 Mar; 105(6):839-43. PubMed ID: 20211328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus.
    Hage FG; Heo J; Franks B; Belardinelli L; Blackburn B; Wang W; Iskandrian AE
    Am Heart J; 2009 Apr; 157(4):771-6. PubMed ID: 19332209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of the heart rate response to adenosine in relation to diabetes mellitus and chronic kidney disease.
    Hage FG; Dean P; Bhatia V; Iqbal F; Heo J; Iskandrian AE
    Am Heart J; 2011 Aug; 162(2):356-62. PubMed ID: 21835298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tachycardia caused by A2A adenosine receptor agonists is mediated by direct sympathoexcitation in awake rats.
    Dhalla AK; Wong MY; Wang WQ; Biaggioni I; Belardinelli L
    J Pharmacol Exp Ther; 2006 Feb; 316(2):695-702. PubMed ID: 16227469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regadenoson: a new myocardial stress agent.
    Al Jaroudi W; Iskandrian AE
    J Am Coll Cardiol; 2009 Sep; 54(13):1123-30. PubMed ID: 19761931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regadenoson.
    Garnock-Jones KP; Curran MP
    Am J Cardiovasc Drugs; 2010; 10(1):65-71. PubMed ID: 20063904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial perfusion imaging laboratory efficiency with the use of regadenoson compared to adenosine and dipyridamole.
    Friedman M; Spalding J; Kothari S; Wu Y; Gatt E; Boulanger L
    J Med Econ; 2013; 16(4):449-60. PubMed ID: 23363331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reclassification of cardiovascular risk in patients with normal myocardial perfusion imaging using heart rate response to vasodilator stress.
    Iqbal FM; Al Jaroudi W; Sanam K; Sweeney A; Heo J; Iskandrian AE; Hage FG
    Am J Cardiol; 2013 Jan; 111(2):190-5. PubMed ID: 23111139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching.
    Iqbal FM; Hage FG; Ahmed A; Dean PJ; Raslan S; Heo J; Iskandrian AE
    JACC Cardiovasc Imaging; 2012 Oct; 5(10):1014-21. PubMed ID: 23058068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine attenuates the duration of coronary vasodilation and changes in hemodynamics induced by regadenoson (CVT-3146), a novel adenosine A2A receptor agonist.
    Zhao G; Messina E; Xu X; Ochoa M; Sun HL; Leung K; Shryock J; Belardinelli L; Hintze TH
    J Cardiovasc Pharmacol; 2007 Jun; 49(6):369-75. PubMed ID: 17577101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reproducibility and prognostic value of serial measurements of heart rate response to regadenoson during myocardial perfusion imaging.
    Andrikopoulou E; AlJaroudi WA; Farag A; Lester D; Patel H; Iskandrian AE; Hage FG
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1493-502. PubMed ID: 27079736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regadenoson as a new stress agent in myocardial perfusion imaging. Initial experience in The Netherlands].
    Jager PL; Buiting M; Mouden M; Oostdijk AH; Timmer J; Knollema S
    Rev Esp Med Nucl Imagen Mol; 2014; 33(6):346-51. PubMed ID: 24862658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and feasibility of regadenoson use for suboptimal heart rate response during symptom-limited standard Bruce exercise stress test.
    Partington SL; Lanka V; Hainer J; Blankstein R; Skali H; Forman DE; Di Carli MF; Dorbala S
    J Nucl Cardiol; 2012 Oct; 19(5):970-8. PubMed ID: 22565239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regadenoson pharmacokinetics and tolerability in subjects with impaired renal function.
    Gordi T; Blackburn B; Lieu H
    J Clin Pharmacol; 2007 Jul; 47(7):825-33. PubMed ID: 17585115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome and age-related progression of aortic stiffness.
    Safar ME; Thomas F; Blacher J; Nzietchueng R; Bureau JM; Pannier B; Benetos A
    J Am Coll Cardiol; 2006 Jan; 47(1):72-5. PubMed ID: 16386667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of sex, metabolic syndrome, and diabetes mellitus on cardiovascular events.
    Mak KH; Ma S; Heng D; Tan CE; Tai ES; Topol EJ; Chew SK
    Am J Cardiol; 2007 Jul; 100(2):227-33. PubMed ID: 17631075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging.
    Hage FG; Dean P; Iqbal F; Heo J; Iskandrian AE
    J Nucl Cardiol; 2011 Dec; 18(6):1086-94. PubMed ID: 21785922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart rate variability and heart rate turbulence in patients with type 2 diabetes mellitus with versus without cardiac autonomic neuropathy.
    Balcioğlu S; Arslan U; Türkoğlu S; Ozdemir M; Cengel A
    Am J Cardiol; 2007 Sep; 100(5):890-3. PubMed ID: 17719340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is regadenoson an appropriate stressor for MPI in patients with left bundle branch block or pacemakers?
    Thomas GS; Kinser CR; Kristy R; Xu J; Mahmarian JJ
    J Nucl Cardiol; 2013 Dec; 20(6):1076-85. PubMed ID: 24132816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.